| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Vascular Biogenics (NASDAQ:VBLT) is set to give its latest quarterly earnings report on Friday, 2023-05-26. Here's what investors need to know before the announcement.
Analysts estimate that Vascular Biogenics will report an earnings per share (EPS) of $-0.15.
Vascular Biogenics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Last quarter the company beat EPS by $0.09, which was followed by a 0.68% increase in the share price the next day.
Here's a look at Vascular Biogenics's past performance and the resulting price change:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.14 | -0.11 | -0.13 | -0.11 |
| EPS Actual | -0.05 | -0.12 | -0.12 | -0.13 |
| Price Change % | 0.68% | 8.58% | -3.53% | 1.95% |
Shares of Vascular Biogenics were trading at $0.2125 as of May 24. Over the last 52-week period, shares are down 89.01%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Vascular Biogenics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VBLT
